|
Thrombectomy before PCI (no, percent)
|
6 (9.4%)
|
64
|
4 (11.8%)
|
34
|
1.29a
|
(0.34; 4.92) 0.71
|
|
Primary stenting (no, percent)
|
19 (29.7%)
|
64
|
8 (23.5%)
|
34
|
0.73a
|
(0.28; 1.90) 0.52
|
|
Stent diameter (mm, mean, range, SD)
|
2.7 (2.0 – 3.5, 0.31)
|
64
|
2.8 (2.0 – 3.5, 0.38)
|
34
|
−0.15b
|
(−0.29; -0.01) 0.04
|
|
Stent length (mm, mean, range, SD)
|
17.6 (8.0 – 58.0, 8.8)
|
64
|
20.7 (8.0 – 44.0, 8.8)
|
34
|
−0.18c
|
(−0.36; -0.00) 0.05
|
|
Drug eluting stent (no., percent)
|
36 (56.3%)
|
64
|
17 (50.0%)
|
34
|
0.78a
|
(0.34; 1.79) 0.56
|
|
Glycoprotein IIB/IIIA antagonists (no., percent)
|
9 ( 14.1%)
|
64
|
8 (24.2%)
|
34
|
1.88a
|
(0.65; 5.43) 0.24
|
|
Duration of x-ray, min (mean, range, SD)
|
18.1 (2.7-220; 28.5 )
|
64
|
20.1 (5.8-51.4; 12.2 )
|
34
|
−0.36c
|
(−0.67; -0.06) 0.02
|
|
Amount of contrast medium, ml (mean, range, SD)
|
225.8 (70–640; 104.0)
|
64
|
307.4 (180–470; 83.9 )
|
34
|
−81.5a
|
(−122.8; -40.3) <0.001
|
